NCT01708915 - Nonivamide/Nicoboxil Ointment in Acute Low Back Pain | Biotech Hunter

Enrollment

805

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

Acute Low Back Pain

Interventions

DRUG

nicoboxil

2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period

DRUG

placebo matching nonivamide + nicoboxil

2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period

DRUG

nonivamide + nicoboxil (Finalgon)

2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period

DRUG

nonivamide

2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period

Trial Locations (37)

Unknown

69.52.49007 Boehringer Ingelheim Investigational Site, Bad Lippspringe

69.52.49003 Boehringer Ingelheim Investigational Site, Berlin

69.52.49004 Boehringer Ingelheim Investigational Site, Berlin

69.52.49026 Boehringer Ingelheim Investigational Site, Berlin

69.52.49032 Boehringer Ingelheim Investigational Site, Berlin

69.52.49033 Boehringer Ingelheim Investigational Site, Berlin

69.52.49041 Boehringer Ingelheim Investigational Site, Berlin

69.52.49027 Boehringer Ingelheim Investigational Site, Cologne

69.52.49035 Boehringer Ingelheim Investigational Site, Cologne

69.52.49040 Boehringer Ingelheim Investigational Site, Cologne

69.52.49002 Boehringer Ingelheim Investigational Site, Einbeck

69.52.49024 Boehringer Ingelheim Investigational Site, Essen

69.52.49031 Boehringer Ingelheim Investigational Site, Essen

69.52.49036 Boehringer Ingelheim Investigational Site, Essen

69.52.49005 Boehringer Ingelheim Investigational Site, Everswinkel

69.52.49039 Boehringer Ingelheim Investigational Site, Fürth

69.52.49018 Boehringer Ingelheim Investigational Site, Goch

69.52.49025 Boehringer Ingelheim Investigational Site, Großheirath-Rossach

69.52.49022 Boehringer Ingelheim Investigational Site, Haag

69.52.49009 Boehringer Ingelheim Investigational Site, Hamburg

69.52.49019 Boehringer Ingelheim Investigational Site, Hamburg

69.52.49015 Boehringer Ingelheim Investigational Site, Kaarst

69.52.49042 Boehringer Ingelheim Investigational Site, Karlsruhe-Rüppurr

69.52.49013 Boehringer Ingelheim Investigational Site, Köthen

69.52.49014 Boehringer Ingelheim Investigational Site, Künzing

69.52.49034 Boehringer Ingelheim Investigational Site, Ludwigshafen

69.52.49028 Boehringer Ingelheim Investigational Site, Messkirch

69.52.49030 Boehringer Ingelheim Investigational Site, Messkirch

69.52.49029 Boehringer Ingelheim Investigational Site, Münster

69.52.49012 Boehringer Ingelheim Investigational Site, Neunkirchen

69.52.49020 Boehringer Ingelheim Investigational Site, Rodgau

69.52.49037 Boehringer Ingelheim Investigational Site, Siegen

69.52.49016 Boehringer Ingelheim Investigational Site, Stockach

69.52.49010 Boehringer Ingelheim Investigational Site, Straßkirchen

69.52.49021 Boehringer Ingelheim Investigational Site, Villingen-Schwenningen

69.52.49023 Boehringer Ingelheim Investigational Site, Wangen

69.52.49011 Boehringer Ingelheim Investigational Site, Weilburg